Filing Details
- Accession Number:
- 0001493152-21-003285
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-10 19:42:12
- Reporting Period:
- 2021-02-08
- Accepted Time:
- 2021-02-10 19:42:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
318306 | Abeona Therapeutics Inc. | ABEO | Pharmaceutical Preparations (2834) | 830221517 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1225978 | Sco Capital Partners Llc | 1330 Avenue Of The Americas, 33Rd Floor New York NY 10019 | Yes | No | Yes | No | |
1294343 | H Steven Rouhandeh | 1330 Avenue Of The Americas, 33Rd Floor New York NY 10019 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-02-08 | 240,000 | $3.01 | 11,359,292 | No | 4 | S | Indirect | SCO Capital Partners LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | SCO Capital Partners LLC |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020.
- The price reported in Column 4 is a weighted average price. The shares weresold in multiple transactions at prices ranging from $3.00 to $3.06, inclusive. TheReporting Person undertakes to provide to the Issuer, any security holder, or theStaff of the SEC, upon request, full information regarding the number of sharesdisposed at each separate price within the ranges set forth in this footnote.